TL;DR: The Centers for Medicare & Medicaid Services modified NCD 25, the National Coverage Determination governing bacterial urine culture testing, effective January 9, 2026. Here's what changes for billing teams.
This update to the CMS urine culture coverage policy clarifies indications, tightens limitations on specific CPT codes, and sets explicit rules on how often certain codes can be billed per encounter. The policy references CPT codes 87086, 87088, 87184, and 87186 in its limitations prose. If your lab or outpatient practice bills these codes for Medicare patients, you need to review your charge capture and documentation protocols before January 9, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Urine Culture, Bacterial — NCD 25 |
| Policy Code | NCD 25 |
| Change Type | Modified |
| Effective Date | January 9, 2026 |
| Impact Level | Medium |
| Specialties Affected | Clinical laboratory, urology, internal medicine, infectious disease, nephrology, transplant medicine |
| Key Action | Audit charge capture for CPT 87086 to confirm one-per-encounter billing, and review documentation for polymicrobial UTI cases billed with 87088, 87184, or 87186 |
CMS Bacterial Urine Culture Coverage Criteria and Medical Necessity Requirements 2026
NCD 25 is the National Coverage Determination governing Medicare coverage of bacterial urine cultures — the lab procedure performed on a urine specimen to identify the probable cause of a presumed urinary tract infection (UTI). The update effective January 9, 2026 doesn't reinvent the coverage policy. It codifies and clarifies the indications and limitations that Medicare Administrative Contractors have been applying inconsistently across regions.
The real issue here is medical necessity documentation. CMS lays out six specific indications for coverage, and your claims need to map to at least one of them. Vague clinical notes won't hold up on audit. Here's what CMS actually requires.
Indication 1: Abnormal urinalysis. A patient's urinalysis shows signs suggesting UTI. That includes abnormal microscopic findings (hematuria, pyuria, bacteriuria), abnormal biochemical results (positive leukocyte esterase, nitrite, protein, or blood), a Gram's stain positive for microorganisms, or a positive bacteriuria screen by a non-culture technique. CMS notes that a urinalysis is not required before ordering a urine culture — but when the clinical workflow includes one, the culture coverage depends on those abnormal results.
Indication 2: Clinical signs and symptoms of UTI. The patient presents with symptoms pointing to a possible UTI. Lower UTI signs include urgency, frequency, nocturia, dysuria, discharge, or incontinence. Upper UTI adds systemic symptoms like fever, chills, lethargy, or costovertebral, abdominal, or pelvic pain. CMS explicitly calls out that elderly, immunocompromised, and neurologically impaired patients may present atypically — with general debility, acute mental status changes, or declining functional status. Document those atypical presentations specifically. A generic note saying "confusion" won't support medical necessity the way "acute mental status change in immunocompromised patient evaluated for UTI source" will.
Indication 3: Urosepsis, fever of unknown origin, or systemic infection without known source. If the clinical picture involves suspected urosepsis or a fever without an identified source, a urine culture is covered. The signs and symptoms used to define sepsis are well-established, and your documentation should reference them directly.
Indication 4: Test-of-cure in complicated infections. This one has a specific limitation. A test-of-cure culture is generally not covered for uncomplicated UTIs. Coverage applies when the patient has a complicating co-existing urinary abnormality — structural or functional abnormalities, calculi, foreign bodies, or ureteral or renal stents — or when there is clinical or laboratory evidence of treatment failure matching Indications 1 or 2. If you're billing test-of-cure cultures on uncomplicated UTIs, expect claim denial.
Indication 5: Preoperative screening before major genitourinary surgery. Selected preoperative cases qualify — specifically, renal transplantation, manipulation or removal of kidney stones, and transurethral surgery of the bladder or prostate. The key word is "selected." Your documentation needs to show why occult infection screening was clinically indicated for that specific patient, not just that they were scheduled for a qualifying procedure.
Indication 6: Renal transplant recipients on immunosuppressive therapy. Urine culture to detect occult infection in this population is covered. This is a straightforward indication, but your documentation should confirm the patient's transplant status and active immunosuppressive therapy. That's the documentation that supports reimbursement when these claims are reviewed.
The source policy does not address prior authorization requirements for urine culture billing under NCD 25. Contact your Medicare Administrative Contractor directly to confirm whether your MAC has prior auth requirements or a local coverage determination that adds restrictions. Don't assume the absence of a national prior auth requirement means your MAC has none.
CMS Urine Culture Exclusions and Non-Covered Indications
The main exclusion here is asymptomatic bacteriuria. The policy summary was truncated at this limitation, but the text begins: "Testing for asymp..." — this is screening for asymptomatic bacteriuria in patients without signs or symptoms or qualifying clinical circumstances.
Routine screening cultures in patients without signs, symptoms, or a qualifying indication are not covered under Medicare. This matters if your practice orders surveillance cultures on low-risk patients as a protocol default. CMS won't reimburse those, and billing them anyway creates claim denial risk and audit exposure.
The other non-covered scenario is test-of-cure in uncomplicated UTIs. CMS is explicit: unless the patient has a complicating urinary abnormality or shows clinical evidence of treatment failure, a follow-up culture to confirm resolution is not a covered service.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Abnormal urinalysis suggesting UTI (hematuria, pyuria, positive leukocyte esterase, positive nitrite, etc.) | Covered | CPT 87086, 87088, 87184, 87186 | Document specific abnormal finding |
| Clinical signs and symptoms of lower or upper UTI | Covered | CPT 87086, 87088, 87184, 87186 | Document atypical presentations explicitly for elderly or immunocompromised patients |
| Suspected urosepsis, fever of unknown origin, or systemic infection without known source | Covered | CPT 87086, 87088, 87184, 87186 | Document sepsis criteria or FUO workup in the note |
| Test-of-cure in complicated UTI (structural abnormality, calculi, foreign body, stent, or treatment failure) | Covered | CPT 87086, 87088, 87184, 87186 | Not covered for uncomplicated UTIs |
| Preoperative screening before major genitourinary surgery (renal transplant, stone removal, transurethral surgery) | Covered — selected cases | CPT 87086, 87088, 87184, 87186 | Must document clinical rationale for individual patient |
| Occult infection surveillance in renal transplant recipients on immunosuppressive therapy | Covered | CPT 87086, 87088, 87184, 87186 | Confirm transplant status and active immunosuppression in documentation |
| Asymptomatic bacteriuria screening without qualifying indication | Not Covered | CPT 87086 | Claim denial risk; NCD 25 explicitly excludes routine screening |
| Test-of-cure in uncomplicated UTI | Not Covered | CPT 87086 | No complicating abnormality and no evidence of treatment failure = no coverage |
CMS Urine Culture Billing Guidelines and Action Items 2026
The billing guidelines under NCD 25 have some specific rules that will catch teams off guard if they're not prepared. Here's what to do before January 9, 2026.
| # | Action Item |
|---|---|
| 1 | Cap CPT 87086 at one unit per encounter. The policy is explicit: CPT 87086 may be used one time per encounter. If your billing system or charge capture allows multiple units of 87086 on a single date of service, fix that before the effective date. This is a straightforward rule, but it generates denials when teams aren't watching unit counts. |
| 2 | Bill CPT 87088, 87184, and 87186 multiple times when the infection is polymicrobial. This is the one area where the policy actually gives you flexibility. These three codes may be billed multiple times — in association with CPT 87086 or independent of it — because urinary tract infections are often polymicrobial. Don't let your system auto-restrict these to one unit. Each significant isolate may warrant a separate billing line. Pull your charge capture rules for these codes and confirm they allow multiple units. |
| 3 | Don't apply colony count restrictions to CPT 87088. The policy explicitly states that colony count restrictions on coverage of CPT 87088 do not apply. Colony counts are highly variable depending on the clinical syndrome, antecedent therapy, collection time, and degree of hydration. If your MAC or internal billing guidelines have been restricting 87088 coverage based on colony count thresholds, that's not consistent with NCD 25. Review those rules now. |
| 4 | Audit your documentation templates for all six covered indications. Work with your medical director or ordering physicians to confirm that notes support one of the six NCD 25 indications specifically. Generic UTI documentation won't cut it on audit. The note needs to reflect the actual clinical picture — abnormal urinalysis results, specific symptoms, transplant status, preoperative context, or the complicating factors that justify a test-of-cure. |
| 5 | Identify and flag asymptomatic bacteriuria screening orders. If your practice has protocols that trigger routine urine cultures without a qualifying clinical indication, those need to be reviewed. Flag any standing orders or protocol-driven cultures that lack documented signs, symptoms, or a covered indication. Billing those under Medicare is a claim denial waiting to happen — and repeated billing of non-covered services creates audit and overpayment risk. |
| 6 | Check your MAC's LCD for any regional variations. NCD 25 sets the national floor. Your Medicare Administrative Contractor may have a local coverage determination that narrows indications further or adds documentation requirements. Pull your MAC's LCD before January 9, 2026 and reconcile it against your billing guidelines. If you're not sure which MAC serves your region, your billing consultant can help you identify it. |
| 7 | Loop in your compliance officer if you have high-volume urine culture billing. If your lab or practice bills these codes frequently for Medicare patients, this policy update is worth a compliance review. Specifically, look at your test-of-cure billing patterns and your unit counts for CPT 87086. If you're not sure how your current billing practices map to NCD 25, talk to your compliance officer before January 9, 2026. |
CPT and ICD-10 Codes for Bacterial Urine Culture Under NCD 25
Disclosure: The Policy Codes field in the NCD 25 source data contains no formal code list. The CPT code references in this post — 87086, 87088, 87184, and 87186 — are drawn from the policy's limitations prose, not a verified code table published by CMS as part of this policy. Billing teams should verify current CPT descriptors against the AMA CPT codebook and confirm applicability with their MAC before relying on these references for claim submission.
The policy's limitations section references four CPT codes by number. Their descriptions below are drawn from the AMA CPT codebook, not from NCD 25 itself.
CPT Codes Referenced in NCD 25 Limitations Prose
| Code | Billing Notes |
|---|---|
| CPT 87086 | One unit per encounter only |
| CPT 87088 | Multiple units allowed; no colony count restriction applies |
| CPT 87184 | Multiple units allowed; may bill independent of 87086 |
| CPT 87186 | Multiple units allowed; may bill independent of 87086 |
For full CPT descriptors, refer to the current AMA CPT codebook. Do not rely on unofficial descriptions for claim submission.
Key ICD-10-CM Diagnosis Codes
The policy does not list specific ICD-10-CM codes. Use diagnosis codes that reflect the covered indication documented in the clinical note. Common applicable codes include those for UTI, urosepsis, fever of unknown origin, and renal transplant status — but select based on the patient's actual documented presentation. Your compliance officer or coding team should confirm ICD-10 mapping to NCD 25 indications for your specific patient mix.
Get the Full Picture for CPT 87086
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.